Rectal bioavailability of 6-mercaptopurine in children with acute lymphoblastic leukaemia: partial avoidance of ?first-pass? metabolism
- 1 June 1992
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 42 (6), 619-622
- https://doi.org/10.1007/bf00265925
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Dose-dependent kinetics of orally administered 6-mercaptopurine in children with leukemiaThe Journal of Pediatrics, 1991
- Diurnal Variation in the Pharmacokinetics and Myelotoxicity of Mercaptopurine in Children With Acute Lymphocytic LeukemiaArchives of Pediatrics & Adolescent Medicine, 1990
- 6-Mercaptopurine Plasma Levels in Children with Acute Lymphoblastic LeukemiaTherapeutic Drug Monitoring, 1989
- Pharmacokinetic determinants of 6-mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemiaClinical Pharmacology & Therapeutics, 1986
- Large Interindividual Variations in the Pharmacokinetics of Oral 6‐Mercaptopurine in Maintenance Therapy of Children with Acute Leukaemia and Non‐Hodgkin LymphomaActa Paediatrica, 1986
- Acute Lymphoblastic Leukemia in ChildhoodPediatric Clinics of North America, 1985
- Variable Bioavailability of Oral MercaptopurineNew England Journal of Medicine, 1983
- Moment analysis for disposition kinetics of several cephalosporin antibiotics in ratsJournal of Pharmacy and Pharmacology, 1983
- THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKAEMIABritish Journal of Haematology, 1980
- Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report.1980